In Vitro Activities of New and Conventional Antifungal Agents against ClinicalScedosporiumIsolates
- 1 January 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (1) , 62-8
- https://doi.org/10.1128/aac.46.1.62-68.2002
Abstract
Read the full review for this F1000Prime recommended article: In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.Keywords
This publication has 39 references indexed in Scilit:
- A Case of Disseminated Scedosporium Apiospermum Infection after Bone Marrow TransplantationMycoses, 2009
- Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificansClinical Microbiology & Infection, 2000
- Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and reviewClinical Microbiology & Infection, 1999
- Clinical Resolution of Scedosporium prolificans Fungemia Associated with Reversal of Neutropenia Following Administration of Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 1996
- , a multi-resistant fungus, from a U.K. AIDS patientJournal of Infection, 1995
- Fatal Disseminated Infection by Scedosporium inflatum after Bone Marrow TransplantationScandinavian Journal of Infectious Diseases, 1993
- Systemically Administered Antifungal AgentsDrugs, 1992
- TerbinafineDrugs, 1992
- DisseminatedScedosporium inflatum infection in a patient with acute myeloblastic leukemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Clinical Pharmacokinetics of Systemic Antifungal DrugsClinical Pharmacokinetics, 1983